← FDA Drug Approvals (Drugs@FDA)

FULVESTRANT

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2021-06-11

Drug application

FDA Application #

ANDA211730

Application type

Abbreviated New Drug Application (Generic)

Brand name

FULVESTRANT

Generic name

Fulvestrant

Active ingredients

FULVESTRANT

Dosage form

SOLUTION

Route

INTRAMUSCULAR

Marketing status

Discontinued

Sponsor

APOTEX

First approval

2021-06-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown